World Journal of Biological Psychiatry

Papers
(The median citation count of World Journal of Biological Psychiatry is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Clinician guidelines for the treatment of psychiatric disorders with nutraceuticals and phytoceuticals: The World Federation of Societies of Biological Psychiatry (WFSBP) and Canadian Network for Mood78
The biology of burnout: Causes and consequences55
Practical recommendations for the management of treatment-resistant depression with esketamine nasal spray therapy: Basic science, evidence-based knowledge and expert guidance43
The impact of the early phase of the COVID-19 pandemic on mental-health services in Europe41
A clinical approach to treatment resistance in depressed patients: What to do when the usual treatments don’t work well enough?38
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines update 2023 on the pharmacological treatment of eating disorders37
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders – Version 3. Part I: Anxiety disorders36
Consensus paper of the WFSBP task force on cannabis, cannabinoids and psychosis35
Personalising transcranial magnetic stimulation for depression using neuroimaging: A systematic review33
Clinical guidelines for the use of lifestyle-based mental health care in major depressive disorder: World Federation of Societies for Biological Psychiatry (WFSBP) and Australasian Society of Lifestyl30
Lifetime and current depression in the German National Cohort (NAKO)23
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders – Version 3. Part II: OCD and PTSD23
Analysis of circulating exosomes reveals a peripheral signature of astrocytic pathology in schizophrenia20
Microglia and HPA axis in depression: An overview of participation and relationship19
Tools for optimising pharmacotherapy in psychiatry (therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests): focus on antidepressants19
Circulating cell-free mitochondrial DNA in brain health and disease: A systematic review and meta-analysis16
Correlation between S100B and severity of depression in MDD: A meta-analysis16
Oral ketamine for depression: An updated systematic review15
Inflammation biomarkers in suicide attempts and their relation to abuse, global functioning and cognition14
Circulating inflammatory markers, cell-free mitochondrial DNA, cortisol, endocannabinoids, and N-acylethanolamines in female depressed outpatients14
Sleep-related traits and attention-deficit/hyperactivity disorder comorbidity: Shared genetic risk factors, molecular mechanisms, and causal effects14
Neurofilament light chain as novel blood biomarker of disturbed neuroaxonal integrity in patients with ketamine dependence14
Cognition-immune interactions between executive function and working memory, tumour necrosis factor-alpha (TNF-alpha) and soluble TNF receptors (sTNFR1 and sTNFR2) in bipolar disorder14
Transcriptomic profiling as biological markers of depression – A pilot study in unipolar and bipolar women14
Spend time outdoors for your brain – an in-depth longitudinal MRI study13
The similar eye movement dysfunction between major depressive disorder, bipolar depression and bipolar mania13
Growth factors in anorexia nervosa: a systematic review and meta-analysis of cross-sectional and longitudinal data12
Severe mental disorders and vaccinations – a systematic review11
Mitochondria’s role in sleep: Novel insights from sleep deprivation and restriction studies11
Malignant catatonia: Severity, treatment and outcome – a systematic case series analysis11
Impact of clozapine on the expression of miR-675-3p in plasma exosomes derived from patients with schizophrenia11
Neuroinflammation and psychiatric disorders: Relevance of C1q, translocator protein (18 kDa) (TSPO), and neurosteroids11
Targeted sequencing approach: Comprehensive analysis of DNA methylation and gene expression across blood and brain regions in suicide victims10
The assessment of childhood maltreatment and its associations with affective symptoms in adulthood: Results of the German National Cohort (NAKO)10
The value of ‘mega cohorts’ for psychiatric research10
Effects of low-dose alcohol exposure in adolescence on subsequent alcohol drinking in adulthood in a rat model of depression10
Social dysfunction is transdiagnostically associated with default mode network dysconnectivity in schizophrenia and Alzheimer’s disease10
SNX29, a new susceptibility gene shared with major mental disorders in Han Chinese population10
Altered expression levels of miR-144-3p and ATP1B2 are associated with schizophrenia9
BDNF blood levels after electroconvulsive therapy in patients with mood disorders: An updated systematic review and meta-analysis9
Newborn differential DNA methylation and subcortical brain volumes as early signs of severe neurodevelopmental delay in a South African Birth Cohort Study8
Genetic variants in miRNAs differentially expressed during brain development and their relevance to psychiatric disorders susceptibility8
Immediate and short-term efficacy of suicide-targeted interventions in suicidal individuals: A systematic review8
Amygdala structure and function in paediatric bipolar disorder and high-risk youth: A systematic review of magnetic resonance imaging findings8
Handedness as a neurodevelopmental marker in schizophrenia: Results from the FACE-SZ cohort8
Effects of testosterone suppression on desire, hypersexuality, and sexual interest in children in men with pedophilic disorder8
Metabolic syndrome components and leukocyte telomere length in patients with major depressive disorder8
Intravenous esketamine leads to an increase in impulsive and suicidal behaviour in a patient with recurrent major depression and borderline personality disorder8
Generalised anxiety and panic symptoms in the German National Cohort (NAKO)8
Treatment strategies for serotonin reuptake inhibitor-resistant obsessive-compulsive disorder: A network meta-analysis of randomised controlled trials7
Autonomic nervous system activity and dialectical behavioral therapy outcome in adolescent borderline personality pathology7
Antipsychotic drug treatment of schizophrenia in later life: Results from the European cross-sectional AMSP study7
Cerebrospinal fluid findings in adult patients with obsessive-compulsive disorder: A retrospective analysis of 54 samples7
The assessment of cognitive function in the German National Cohort (NAKO) – Associations of demographics and psychiatric symptoms with cognitive test performance7
The potential of biomarkers for diagnosing insomnia: Consensus statement of the WFSBP Task Force on Sleep Disorders7
Volatile organic compounds from exhaled breath in schizophrenia7
A systematic review and meta-analysis of optical coherence tomography studies in schizophrenia, bipolar disorder and major depressive disorder6
5-HT2A receptor-mediated Gαq/11 activation in psychiatric disorders: A postmortem study6
DNA methylation in people with anorexia nervosa: Epigenome-wide patterns in actively ill, long-term remitted, and healthy-eater women6
Evidence and expert consensus based German guidelines for the use of repetitive transcranial magnetic stimulation in depression6
General cognitive ability assessment in the German National Cohort (NAKO) – The block-adaptive number series task6
Alexithymia and cortisol awakening response in people with eating disorders6
NBQX attenuates relapse of nicotine seeking but not nicotine and methamphetamine self-administration in rats6
Increase in thalamic cerebral blood flow is associated with antidepressant effects of ketamine in major depressive disorder6
Mortality and acute somatic events following electroconvulsive therapy in patients with pre-existing somatic comorbidity – A register-based nationwide Danish cohort study6
BST-1 as a serum protein biomarker involved in neutrophil infiltration in schizophrenia6
Phase-and disorder-specific differences in peripheral metabolites of the kynurenine pathway in major depression, bipolar affective disorder and schizophrenia5
Pre-treatment plasma cytokine levels as potential predictors of short-term remission of depression5
Differentiating melancholic and non-melancholic depression via biological markers: A review5
Systematic review of genome-wide association studies of anxiety disorders and neuroticism5
Inflammatory and oxidative endophenotypes in borderline personality disorder: A biomarker cluster analysis5
Sex difference in lipid levels in first-diagnosed drug-naïve depression patients: A case-control and 12-weeks follow-up study5
The pattern of inflammatory markers during electroconvulsive therapy in older depressed patients5
Metabolic indices in schizophrenia: Association of negative symptoms with higher HDL cholesterol in female patients5
Neurocognitive profile of adolescents with early-onset schizophrenia and their unaffected siblings4
Physical activity and childhood trauma experiences in patients with schizophrenia or bipolar disorders4
Effect of anxiolytic drug silexan on sleep – a narrative review4
Long-term cortisol stress response in depression and comorbid anxiety is linked with reduced N-acetylaspartate in the anterior cingulate cortex4
Cytokine level in patients with mood disorder, alcohol use disorder and their comorbidity4
Peripheral blood MicroRNAs as biomarkers of schizophrenia: expectations from a meta-analysis that combines deep learning methods4
Inefficient integration during multiple facial processing in pre-morbid and early phases of psychosis4
14-3-3 proteins at the crossroads of neurodevelopment and schizophrenia4
Impact of ZNF804A rs1344706 or CACNA1C rs1006737 polymorphisms on cognition in patients with severe mental disorders: A systematic review and meta-analysis4
Investigating pupillometry to detect emotional regulation difficulties in post-traumatic stress disorder4
The relationship between cognitive impairment and superoxide dismutase activity in untreated first-episode patients with schizophrenia4
Decline of stress resilience in aging rats: Focus on choroid plexus-cerebrospinal fluid-hippocampus4
Association between neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, and C-reactive protein levels and metabolic status in patients with a bipolar disorder4
Genome-wide association study detected novel susceptibility genes for social cognition impairment in people with schizophrenia4
Impulsivity and eating disorders: The relationship between serum 25-hydroxyvitamin D and different impulsivity facets in a transdiagnostic sample4
Vitamin B12, homocysteine, and folic acid in patients suffering from bipolar disorders: Relationship with suicide4
Polygenic risk for traumatic loss-related PTSD in US military veterans: Protective effect of secure attachment style4
Endocannabinoids and addiction memory: Relevance to methamphetamine/morphine abuse4
Resting state functional brain imaging in obsessive-compulsive disorder across genders3
A prognostic study on the effect of post-traumatic stress disorder on cerebral ischaemia reperfusion-induced stroke3
Electroacupuncture alleviates depression-like behaviours via a neural mechanism involving activation of Nucleus Accumbens Shell3
Venlafaxine and O-desmethylvenlafaxine serum levels are positively associated with antidepressant response in elder depressed out-patients3
Novel anti-cytoplasmic antibodies in cerebrospinal fluid and serum of patients with chronic severe mental disorders3
Abnormal functional connectivity of brain regions associated with fear network model in panic disorder3
Could serum endocannabinoid and N-acylethanolamine levels be important in bipolar disorder?3
P300 parameters in major depressive disorder: A systematic review and meta-analysis3
Common changes in rat cortical gene expression after valproate or lithium treatment particularly affect pre- and post-synaptic pathways that regulate four neurotransmitters systems3
A novel genetic variant potentially altering the expression of MANBA in the cerebellum associated with attention deficit hyperactivity disorder in Han Chinese children3
Short term ketamine treatment in patient with bipolar disorder with comorbidity with borderline personality disorder: Focus on impulsivity3
Impaired response to sleep deprivation in heterozygous Disc1 mutant mice3
The relationship between alterations in plasma metabolites and treatment responses in antipsychotic-naïve female patients with schizophrenia3
Relationships between global functioning and neuropsychological predictors in subjects at high risk of psychosis or with a recent onset of depression3
Genetics of human startle reactivity: A systematic review to acquire targets for an anxiety endophenotype3
Genome-wide association study of suicidal behaviour severity in mood disorders3
Metformin attenuates depressive-like behaviour of methamphetamine withdrawal in mice: A mechanistic approach3
Blood brain barrier permeability increases with age in individuals with 22q11.2 deletion syndrome3
No neurochemical evidence of neuronal injury or glial activation in children with Paediatric Acute-onset Neuropsychiatric Syndrome. An explorative pilot study3
Executive functioning in adults with borderline personality disorder and first-degree biological relatives3
Systems consolidation and fear memory generalisation as a potential target for trauma-related disorders3
0.22030210494995